AquaPass Ltd
Rotem Guez Katzenellenbogen currently serves as Chief Commercial Officer at AquaPass Ltd since September 2023. Previously, Rotem was the VP of Business Development & Marketing at Vascular Graft Solutions from August 2015 to October 2023. Rotem also held the position of VP Clinical Affairs at V-Wave from April 2014 to November 2015 and served as VP Business Development & Clinical Operations at GardiaMedical from 2012 to 2014. Early career roles include Clinical Manager at Life-Bond Ltd. (2010-2012), Program Manager, Regional Study Manager for the US-IDE Study, and Clinical Research Associate at Dune Medical Devices (2006-2011). Additionally, Rotem served as a Lieutenant in the Israel Defense Forces from October 1996 to December 1999. Rotem completed education at the Technion - Israel Institute of Technology between 2002 and 2006.
This person is not in any teams
This person is not in any offices
AquaPass Ltd
AquaPass Ltd. is the developer and manufacturer of innovative solutions for the treatment of fluid overload in heart failure, renal failure, and lymphedema patients. The treatment is non-invasive and bypasses the renal system. It is intended to be used in the hospital or at home. Initial clinical trials confirmed the safety and performance of the system in chronic heart failure (CHF) patients and in end-stage renal disease (ESRD) patients.